ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCY..TRBGCZEEHUPLSK..HRIS..MTNO....SM..................*JBDM Ver 0.1.67 (18 Oct 2017) - 2999001/0The file contains technical information submitted after the application was filed and not included in this specification2424527CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120190717W173deBibliographieenBibliographyfrBibliographieEP09844195.9200907282011111720170424enenen38716620090429US2019071720192920120307201210201904102019152018102520190717201929A61K 31/353 20060101AFI20130919BHEP A61K 45/06 20060101ALI20130919BHEP A61K 31/4741 20060101ALI20130919BHEP A61K 31/519 20060101ALI20130919BHEP deMASTZELLENSTABILISATOREN ZUR PROPHYLAXE ODER BEHANDLUNG VON LAMINITISenMAST CELL STABILIZERS TO PREVENT OR TREAT LAMINITISfrSTABILISATEURS DE MASTOCYTES UTILISÉS POUR PRÉVENIR OU TRAITER LA FOURBUREWO-A1-2008/034740US-A- 4 419 352US-A1- 2006 173 071US-A1- 2009 304 648US-B2- 6 534 52620130925OWEN, Charles, F.P.O. Box 620694Littleton, CO 80162USWillowcroft Pharm Inc.101617313RIC/FP679595914260 W. Newberry Road, 363Newberry, FL 32669-2765USMewburn Ellis LLP101783151City Tower 40 Basinghall StreetLondon EC2V 5DEGBATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTROSESISKSMTRUS200905194720090728enWO201012654420101104201044